GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Metis Global Partners LLC

Metis Global Partners LLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% in the third quarter, HoldingsChannel reports. The institutional investor owned 17,467 shares of the company’s stock after buying an additional 367 shares during the period. Metis Global Partners LLC’s holdings in GE HealthCare Technologies were worth $1,639,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in GEHC. Schulhoff & Co. Inc. acquired a new position in GE HealthCare Technologies during the third quarter valued at $201,000. KBC Group NV boosted its position in GE HealthCare Technologies by 179.0% in the 3rd quarter. KBC Group NV now owns 184,258 shares of the company’s stock worth $17,292,000 after purchasing an additional 118,214 shares in the last quarter. Huntington National Bank boosted its position in GE HealthCare Technologies by 7.9% in the 3rd quarter. Huntington National Bank now owns 6,787 shares of the company’s stock worth $637,000 after purchasing an additional 498 shares in the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its stake in shares of GE HealthCare Technologies by 375.2% during the 3rd quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 37,297 shares of the company’s stock worth $3,500,000 after purchasing an additional 29,448 shares during the period. Finally, ICICI Prudential Asset Management Co Ltd increased its holdings in shares of GE HealthCare Technologies by 18.9% during the 3rd quarter. ICICI Prudential Asset Management Co Ltd now owns 5,961 shares of the company’s stock valued at $559,000 after purchasing an additional 947 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 1.4 %

Shares of GEHC stock opened at $81.76 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock’s fifty day moving average is $88.70 and its two-hundred day moving average is $83.48. The firm has a market capitalization of $37.35 billion, a P/E ratio of 22.46, a PEG ratio of 3.02 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s revenue for the quarter was up .9% on a year-over-year basis. During the same period last year, the firm posted $0.99 earnings per share. Research analysts expect that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.30%.

Analyst Ratings Changes

Several analysts recently commented on GEHC shares. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus boosted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.